NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Sartorius Stedim Biotech S.A (PA: DIM)

 
DIM Technical Analysis
4
As on 3rd Dec 2025 DIM STOCK Price closed @ 215.20 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 191.79 & Buy for SHORT-TERM with Stoploss of 198.47 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

DIMSTOCK Price

Open 207.50 Change Price %
High 215.20 1 Day 7.80 3.76
Low 207.50 1 Week 20.65 10.61
Close 215.20 1 Month 3.00 1.41
Volume 112643 1 Year 34.10 18.83
52 Week High 225.50 | 52 Week Low 152.90
 
PA France Most Active Stocks
ALADO 0.00 %
FTI 5.91 -1.66%
VIEDS 0.72 4.35%
ALNRG 0.01 0.00%
ETL 1.97 -5.29%
CGG 0.69 -2.82%
ALRPD 0.00 %
ALHYG 0.01 0.00%
SIGHT 0.11 -21.43%
ALTBG 2.88 8.27%
 
PA France Top Gainers Stocks
MLGEQ 0.03 50.00%
PROAC 0.06 50.00%
ALPCV 0.33 26.92%
GNRO 0.05 25.00%
EKI 1.74 21.68%
WAVE 56.30 13.97%
WAVE 56.30 13.97%
WAVE 56.30 13.97%
WAVE 56.30 13.97%
ALIMR 1.99 13.71%
 
PA France Top Losers Stocks
AKOM 4.06 -37.05%
AKOM 4.06 -37.05%
MLFTI 0.04 -33.33%
FPN 0.02 -33.33%
SIGHT 0.11 -21.43%
GBT 14.20 -20.40%
GBT 14.20 -20.40%
GBT 14.20 -20.40%
ALSAS 4.32 -17.71%
ORP 7.90 -12.03%
 
 
DIM
Daily Charts
DIM
Intraday Charts
Whats New @
Bazaartrend
DIM
Free Analysis
 
DIM Important Levels Intraday
RESISTANCE230.04
RESISTANCE225.28
RESISTANCE222.34
RESISTANCE219.40
SUPPORT211.00
SUPPORT208.06
SUPPORT205.12
SUPPORT200.36
 
DIM Forecast December 2025
4th UP Forecast281.78
3rd UP Forecast260.43
2nd UP Forecast247.23
1st UP Forecast234.03
1st DOWN Forecast196.37
2nd DOWN Forecast183.17
3rd DOWN Forecast169.97
4th DOWN Forecast148.62
 
DIM Weekly Forecast
4th UP Forecast255.09
3rd UP Forecast242.30
2nd UP Forecast234.39
1st UP Forecast226.48
1st DOWN Forecast203.92
2nd DOWN Forecast196.01
3rd DOWN Forecast188.10
4th DOWN Forecast175.31
 
DIM Forecast2025
4th UP Forecast390.65
3rd UP Forecast334.38
2nd UP Forecast299.6
1st UP Forecast264.82
1st DOWN Forecast165.58
2nd DOWN Forecast130.8
3rd DOWN Forecast96.02
4th DOWN Forecast39.75
 
 
DIM Other Details
Segment EQ
Market Capital 43451432960.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website >
 
DIM Address
DIM
 
DIM Latest News
 
Your Comments and Response on Sartorius Stedim Biotech S.A
 
DIM Business Profile
Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, filtration, purification, and fluid management services; single-use and reusable hollow-fiber membrane devices, as well as presterilized assemblies for cell and gene therapy applications; and cell harvesting and various other solutions for intensified bioprocesses. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. It serves manufacturers of pharmaceuticals, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG. Address: Zone Industrielle Les Paluds, Aubagne, France, 13781
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service